Completed
14AWHGA Randomized, Double-blind, Placebo Controlled, Parallel Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants
What is being tested
Activamp
+ Placebo
Dietary SupplementOther
Who is being recruted
Body Weight
+ Signs and Symptoms
+ Pathological Conditions, Signs and Symptoms
From 21 to 55 Years
+27 Eligibility Criteria
How is the trial designed
Placebo-ControlledPhase 2
Interventional
Study Start: September 2014
Summary
Principal SponsorKGK Science Inc.
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: September 1, 2014
Actual date on which the first participant was enrolled.The purpose of this study is to determine the effects of Activamp, a product containing gynostemma pentaphyllum extract, on body weight, fat loss and metabolic markers in healthy overweight adults.
Official TitleA Randomized, Double-blind, Placebo Controlled, Parallel Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants
Principal SponsorKGK Science Inc.
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 21 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Body WeightSigns and SymptomsPathological Conditions, Signs and Symptoms
Criteria
10 inclusion criteria required to participate
Healthy male or female 21-55 years of age
BMI of 25.0 kg/m2 to 29.9 kg/m2 (± 1.0kg/m2)
Must have negative urine pregnancy test at screening
Female subject of childbearing potential must agree to use a medically approved method of birth control and have a negative urine pregnancy test result.
Show More Criteria
17 exclusion criteria prevent from participating
Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial
Subject who have experienced a greater than 10% variation in body weight in the past 3 months
History of, or current diagnosis of any major diseases of the cardiovascular, hepatic, renal, gastrointestinal, pulmonary or endocrine systems
History of surgery for weight loss (including gastric bypass or lapband)
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalCapsules containing 225mg of Activamp (Gynostemma pentaphyllum extract), 1 capsule taken twice daily for 12 weeks
Group II
Placebo1 capsule taken twice daily for 12 weeks
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
CompletedOne Study Center